Moderna, Inc. (0QF.F)
EUR 37.5
(-3.85%)
EUR 37.5
(-3.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.23 Billion USD | -145.0% |
| 2022 | 9.42 Billion USD | -29.15% |
| 2021 | 13.29 Billion USD | 1842.27% |
| 2020 | -763.14 Million USD | -39.84% |
| 2019 | -545.72 Million USD | -32.05% |
| 2018 | -413.26 Million USD | -53.43% |
| 2017 | -269.35 Million USD | -20.37% |
| 2016 | -223.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.26 Billion USD | -21200.0% |
| 2024 Q2 | -1.36 Billion USD | -7.66% |
| 2023 Q4 | 6 Million USD | 100.3% |
| 2023 FY | -4.23 Billion USD | -145.0% |
| 2023 Q1 | -366 Million USD | -123.16% |
| 2023 Q2 | -1.86 Billion USD | -410.11% |
| 2023 Q3 | -2.01 Billion USD | -7.77% |
| 2022 Q3 | 1.16 Billion USD | -52.35% |
| 2022 FY | 9.42 Billion USD | -29.15% |
| 2022 Q2 | 2.44 Billion USD | -42.11% |
| 2022 Q1 | 4.22 Billion USD | -21.87% |
| 2022 Q4 | 1.58 Billion USD | 35.51% |
| 2021 FY | 13.29 Billion USD | 1842.27% |
| 2021 Q3 | 3.55 Billion USD | 16.2% |
| 2021 Q1 | 1.26 Billion USD | 560.3% |
| 2021 Q2 | 3.06 Billion USD | 141.86% |
| 2021 Q4 | 5.41 Billion USD | 52.05% |
| 2020 FY | -763.14 Million USD | -39.84% |
| 2020 Q4 | -275.03 Million USD | -16.98% |
| 2020 Q3 | -235.11 Million USD | -92.52% |
| 2020 Q2 | -122.12 Million USD | 6.67% |
| 2020 Q1 | -130.86 Million USD | -0.23% |
| 2019 FY | -545.72 Million USD | -32.05% |
| 2019 Q1 | -141.83 Million USD | 7.32% |
| 2019 Q2 | -143.93 Million USD | -1.48% |
| 2019 Q3 | -130.85 Million USD | 9.09% |
| 2019 Q4 | -130.55 Million USD | 0.23% |
| 2018 Q3 | -85.81 Million USD | 11.54% |
| 2018 Q4 | -153.03 Million USD | -78.32% |
| 2018 FY | -413.26 Million USD | -53.43% |
| 2018 Q1 | -77.4 Million USD | -85.05% |
| 2018 Q2 | -97.01 Million USD | -25.34% |
| 2017 Q4 | -41.82 Million USD | 0.0% |
| 2017 FY | -269.35 Million USD | -20.37% |
| 2016 FY | -223.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BioNTech SE | 690.4 Million EUR | 713.992% |
| CureVac N.V. | -274.2 Million EUR | -1445.912% |
| Biotest Aktiengesellschaft | 143.5 Million EUR | 3054.007% |
| Biotest Aktiengesellschaft | 143.5 Million EUR | 3054.007% |
| BRAIN Biotech AG | -6.71 Million EUR | -63027.327% |
| Formycon AG | -369 Thousand EUR | -1148680.488% |
| Heidelberg Pharma AG | -21.2 Million EUR | -19886.045% |
| Medigene AG | -16.14 Million EUR | -26149.303% |